A case report on deficiency of adenosine deaminase 2 with relapse–remission course and analysis of genotype–phenotype correlation
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63568 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Qianyun Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Adenosine Deaminase, Genetic Association Studies, Intercellular Signaling Peptides and Proteins, Mutation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: West China Second University Hospital, National Natural Science Foundation of China Youth Science Foundation Project, Fundamental Research Funds for the Central University.
Abstract (Originalsprache)
Deficiency of adenosine deaminase 2 (DADA2) is a monogenic disease caused by biallelic mutations in adenosine deaminase 2 (ADA2). The varying phenotypes of the disease often lead to delayed diagnosis or misdiagnosis. We report an 11‐year‐old boy with DADA2 and provide a preliminary analysis of genotype–phenotype correlation. The age of onset of the disease was 8 years old. The disease successively involved the brainstem, muscles, joints, and cerebrum. After three relapse–remission episodes over 3 years, the patient was finally diagnosed with DADA2 by whole‐exome sequencing. Compound heterozygous variants in the ADA2 gene (NM_001282225.2: c.1072G>A, p.Gly358Arg; c.419dupC, p.Arg141Lysfs*37) were found in the patient. He did not receive anti‐TNF therapy and had no relapse after a 8‐month follow‐up. We identified a novel variant of the ADA2 gene, and the associated disease course may follow a relapse–remission pattern. Homozygous mutations of p.Gly358Arg can cause pure red cell aplasia, whereas compound heterozygous variations may lead to different phenotypes. Variants in the catalytic domain and frameshift mutations may also cause relatively benign phenotypes besides causing hematological disorders. Further studies are needed to clarify the genotypic–phenotypic relationship of this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Pediatrics, Key Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of the Ministry of Education, Sichuan University, Chengdu, Sichuan, China.
- Department of Pediatrics, Key Laboratory of Development and Maternal and Child Diseases of Sichuan Province, Sichuan University, Chengdu, Sichuan, China.
- Cipher Gene LLC, Beijing, China.
- Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
ORCID-Profile: Qianyun Cai, Zhongjie Zhou
Förderung
- West China Second University Hospital
- National Natural Science Foundation of China Youth Science Foundation Project
- Fundamental Research Funds for the Central University
- National Key R&D Program of China
- National Key Research and Development Program of China
Zitieren
APA
Cai, Q., Feng, F., Tian, Y., Luo, R., Mu, D., Yang, F., Yang, Z., & Zhou, Z. (2024). A case report on deficiency of adenosine deaminase 2 with relapse–remission course and analysis of genotype–phenotype correlation. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63568
Vancouver
Cai Q, Feng F, Tian Y, Luo R, Mu D, Yang F, et al. A case report on deficiency of adenosine deaminase 2 with relapse–remission course and analysis of genotype–phenotype correlation. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63568
BibTeX
@article{Cai2024,
author = {Cai, Qianyun and Feng, Fan and Tian, Yanmei and Luo, Rong and Mu, Dezhi and Yang, Fan and Yang, Zuozhen and Zhou, Zhongjie},
title = {A case report on deficiency of adenosine deaminase 2 with relapse–remission course and analysis of genotype–phenotype correlation},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63568}
}
EUVIMED